Tarsus Pharmaceuticals, Inc. (TARS) Ownership

$41.36

$0.19 (-0.46%)
Last update: 03:55 PM EST
Day's range
$40.84
Day's range
$41.86

Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 05/15/2025 3.32 M $170.34 M   2.46% 8.43%
BLACKROCK, INC. 05/02/2025 3.15 M $162.01 M   -10.88% 8.02%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 2.61 M $134.09 M   3.09% 6.63%
JENNISON ASSOCIATES LLC 05/05/2025 2.49 M $128.05 M   -0.30% 6.34%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 2.45 M $126.10 M   8.87% 6.24%
VANGUARD GROUP INC 05/09/2025 2.23 M $114.38 M   5.27% 5.66%
MORGAN STANLEY 05/15/2025 2.01 M $103.40 M   2.22% 5.12%
TORONTO DOMINION BANK 05/15/2025 1.87 M $96.31 M   -1.81% 4.76%
DEEP TRACK CAPITAL, LP 05/15/2025 1.48 M $76.25 M   100.00% 3.77%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 1.40 M $71.79 M   -11.97% 3.55%
LORD, ABBETT & CO. LLC 05/13/2025 1.33 M $68.41 M   4.04% 3.38%
ASSENAGON ASSET MANAGEMENT S.A. 04/15/2025 1.13 M $57.81 M   -1.88% 2.86%
CITADEL ADVISORS LLC 05/15/2025 992.64 K $50.99 M   1,151.11% 2.52%
STATE STREET CORP 05/15/2025 910.72 K $46.78 M   -0.67% 2.31%
MACQUARIE GROUP LTD 05/15/2025 892.78 K $45.86 M   9.42% 2.27%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 865.43 K $44.47 M   3.17% 2.20%
INVESCO LTD. 05/12/2025 826.52 K $42.46 M   -11.33% 2.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 717.85 K $36.88 M   100.00% 1.82%
ORBIMED ADVISORS LLC 05/15/2025 653.74 K $33.58 M   100.00% 1.66%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/14/2025 603.21 K $30.99 M   -12.74% 1.53%
JANUS HENDERSON GROUP PLC 05/15/2025 512.96 K $26.52 M   4,009.60% 1.30%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 510.00 K $26.20 M   100.00% 1.30%
ENSIGN PEAK ADVISORS, INC 05/14/2025 487.31 K $25.03 M   -14.52% 1.24%
IKARIAN CAPITAL, LLC 05/15/2025 485.02 K $24.92 M   -20.19% 1.23%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 433.17 K $22.25 M   -5.99% 1.10%
BANK OF AMERICA CORP /DE/ 05/15/2025 429.14 K $22.05 M   27.02% 1.09%
GILDER GAGNON HOWE & CO LLC 05/15/2025 416.81 K $21.41 M   3.11% 1.06%
D. E. SHAW & CO., INC. 05/15/2025 410.68 K $21.10 M   12.35% 1.04%
CORMORANT ASSET MANAGEMENT, LP 05/15/2025 400.00 K $20.55 M   -20.00% 1.02%
NORTHERN TRUST CORP 05/13/2025 363.43 K $18.67 M   1.63% 0.92%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 308.23 K $15.83 M   -9.69% 0.78%
GOLDMAN SACHS GROUP INC 06/27/2025 301.51 K $15.49 M   -5.40% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 290.32 K $14.91 M   -1.15% 0.74%
05/12/2025 264.52 K $13.59 M   100.00% 0.67%
MILLENNIUM MANAGEMENT LLC 05/15/2025 247.20 K $12.70 M   -61.62% 0.63%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 246.84 K $12.68 M   151.89% 0.63%
CUTTER CAPITAL MANAGEMENT, LP 05/15/2025 205.00 K $10.53 M   82.22% 0.52%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2025 200.00 K $10.27 M   -42.86% 0.51%
TFG ASSET MANAGEMENT GP LTD 05/15/2025 178.47 K $9.17 M   -10.77% 0.45%
SANDS CAPITAL VENTURES, LLC 05/14/2025 170.00 K $8.73 M   0.00% 0.43%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 04/24/2025 168.72 K $8.67 M   -6.85% 0.43%
DEUTSCHE BANK AG\ 05/09/2025 151.42 K $7.78 M   -1.32% 0.38%
ATIKA CAPITAL MANAGEMENT LLC 05/14/2025 144.40 K $7.42 M   -18.51% 0.37%
J. GOLDMAN & CO LP 05/15/2025 140.29 K $7.21 M   7.75% 0.36%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 134.62 K $6.92 M   6,112.14% 0.34%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 05/09/2025 130.29 K $6.69 M   0.15% 0.33%
ALLY BRIDGE GROUP (NY) LLC 05/15/2025 127.93 K $6.57 M   -26.11% 0.33%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 121.27 K $6.23 M   -22.46% 0.31%
PRUDENTIAL FINANCIAL INC 05/13/2025 120.81 K $6.21 M   -18.78% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 116.11 K $5.96 M   -15.12% 0.30%

Tarsus Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 214 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:

RTW INVESTMENTS, LP: 3.32 M

BlackRock, Inc.: 3.15 M

Paradigm Biocapital Advisors LP: 2.61 M

JENNISON ASSOCIATES LLC: 2.49 M

TANG CAPITAL MANAGEMENT LLC: 2.45 M

VANGUARD GROUP INC: 2.23 M

109.69% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 48.09 M shares in the last 24 months. This purchase volume represents approximately $1.98 B in transactions.